the lawmakers said insulin was a "critical public health need" and they reminded them that patients with Type 1 diabetes need steady access to short-acting insulin. Which insulin brands are in ...

Novo Nordisk is gradually ending production of human insulin pens, the drugmaker told Reuters, as it spends billions to ramp ...

Lucrative weight loss drugs are new focus for diabetes patients The insulin supply ... health need" and they reminded them ...

Lawmakers have underscored the importance of steady access to short-acting insulin, which is essential for patients with Type 1 diabetes. Several factors have contributed to the shortages.

“It doesn’t ever stop.” People with type 1 and some with type 2 can face multiple daily injections of insulin. Short-acting insulin covers the spike in glucose that comes with meal ...

These findings may usher in a new era in diabetes treatment without ... of hypoglycaemia and partly covering the need for fast-acting insulin at mealtime. The combination of these two features ...

“The combination of these two features should allow for more aggressive insulin titration without increasing the risk of hypoglycemia. This could improve both the short-term and long-term risks ...

The use of the older "follow-on" route to approve the biosimilar represents yet another way in which the FDA's new commissioner ... The FDA approved its short-acting insulin, Fiasp (insulin ...

Summary: Insulin detemir is a long-acting, neutral, and soluble insulin analogue with a lower within-subject variability of fasting plasma glucose levels than isophane insulin human (NPH insulin ...

Advocates for diabetes patients who need insulin to survive worry the nation's supply is unreliable. Meanwhile, use of ...

Lucrative weight loss drugs are new focus for diabetes patients The ... them that patients with Type 1 diabetes need short-acting insulin. "We are concerned that continued supply disruptions ...